Trial intelligence / Profile preview

Bavituximab + Paclitaxel + Carboplatin in Advanced Breast Cancer

NCT00669565Phase 2Completed

Sponsor
Avid Bioservices, Inc.
Start
Jul 2008
Primary completion
Jul 2010
Modality
Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
Countries
1
01

Overview

A Phase 2 trial of bavituximab in breast cancer, sponsored by Avid Bioservices, Inc.. Started Jul 2008; status: completed.

02

Drugs

bavituximab
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00669565.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00669565.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call